Taurx Is A Clinical Stage Pharmaceutical Company Founded In 2002 In Singaporewith Research And Operations Based In Aberdeenscotlandthe Company Focuses On Developing Treatments For Neurodegenerative Diseasesparticularly Alzheimerae S Diseaseby Targeting Tau Protein Aggregationled By Co Founder And Executive Chairman Professor Claude Mwischiktaurx Has Been At The Forefront Of Research Into Tau Aggregation Inhibitors Since The 1990S The Company Is Known For Its Innovative Drug Developmentparticularly Small Molecule Inhibitors That Dissolve Tau Aggregates And Prevent Neurodegenerationtaurx Also Collaborates With Genting Taurx Diagnostics To Create Blood Tests For Early Dementia Detectionthe Company Conducts Global Clinical Trialsincluding The Recent Lucidity Trialto Assess The Efficacy And Safety Of Its Treatmentstaurx Aims To Improve The Quality Of Life For Patients With Alzheimerae S Diseasefrontotemporal Dementiaand Related Tauopathies Through Early Diagnosis And Disease Modifying Therapies
